Home / Success Plan (Lead-based) – Terms & Conditions
By subscribing to the Success Plan (Lead-based), you agree to the following plan-specific terms. These apply in addition to the MAI CDMO Legal Terms.
With the Success Plan (Lead-based) you get:
Note: Access to projects facilitates outreach but does not guarantee any response, lead volume, or awarded projects.
The fee is €200 per qualified lead.
Leads that do not meet the definition of a qualified lead will not be invoiced.
Payment must be made by bank transfer. Each qualified lead will be invoiced individually, and payment is due within 30 days of invoice date, to the account provided on the invoice.
A lead will be considered qualified if it comes from a specific individual, with a real and described job title, using the corporate email address of their company, representing a potential pharmaceutical client, and if the inquiry described is compatible with your capabilities (even if further discussions later prove otherwise).
In the event of non-payment, access to leads may be suspended until the payment is received in the provider’s account. During this period, the subscription will remain on the Basic Plan with reduced features.
This clause is established pursuant to the freedom of contract recognized in the Spanish Commercial Code (arts. 1 et seq.) and Civil Code (art. 1,261), as well as Law 7/1998, of April 13, on General Conditions of Contracting, last updated 16/03/2019, ensuring clarity, precision, and transparency for the parties.
2025-11-05
Mabion is a CDMO company specializing in the advanced manufacturing and development of biological products, with extensive experience in monoclonal antibodies. Founded in 2007 and headquartered in the EU, in Poland.
See more
2025-10-15
Cultiply is a specialized biotechnology company dedicated to industrial microbiology and fermentation technologies for biological processes. This company is focused on offering a complete innovation platform, from the idea phase to industrial scaling.
See more
2025-09-22
Connecting Leaders in Biologics Manufacturing
See more
The Hérouville-Saint-Clair site, located near Caen, in Normandy, specializes in the manufacture and filling of injectable and non-injectable sterile liquid products. It has a pharmaceutical surface area of 17,900 m2 over 10 hectares and employs 290 people.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Manufacturing services,...
Batch Size / Reactor: Small, Medium
Certifications: EMA (EU GMP), FDA (cGMP), NMPA (China GMP), ANVISA...
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK), TGA...
Tubilux Pharma: registered office; manufacturing facility
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Commercial (Phase IV), Human, Veterinary
Services: Regulatory services, Development services,...
Batch Size / Reactor: Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), TGA (Australia GMP),...
Markets: FDA (USA), EMA (EU), TGA (Australia), ANVISA...
Sterile manufacturing solutions (small molecules) in flexible bags and vials.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
Lannetts main manufacturing site sits in Seymour, Indiana, and includes capabilities for Oral Solid Dose (OSD) and Liquids.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Markets: COFEPRIS (Mexico), FDA (USA), EMA (EU), PMDA...
Reliable CDMO partner for aseptic manufacturing and lyophilization of biologics and injectable drugs.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services,...
Batch Size / Reactor: N/A
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Markets: INVIMA (Colombia), FDA (USA), EMA (EU), MHRA (UK),...
Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Markets: FDA (USA), EMA (EU)
Commercial API Small Molecules Synthesis
Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, FDA (cGMP), ECOVADIS
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
CDMO Sterile Oncology Drugs
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Manufacturing services, Analytical / QC services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: EMA (EU GMP)
Markets: EMA (EU)
If you have any questions or suggestions, click here. We will be happy to assist you.
